Hydroxyphenylundecane, a process for their production and their use

US7112608B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Cordula Hopmann · Berlin, DE
• Martin Knauf · Frankfurt, DE
• Mark Brönstrup · Frankfurt, DE
• Astrid Markus-Erb · Liederbach, DE
• Luigi Toti · Hochheim, DE

Key dates

• Filing date: Oct 1, 2003
• Grant date: Sep 26, 2006
• Expiry date: Oct 1, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12R2001/645
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I),a method for the preparation of said compounds by cultivation of the fungus Cryphonectria parasitica, DSM 14453, and their use as pharmaceuticals, i.e. for the treatment of Alzheimer's Disease, Parkinson's Disease, Huntington's Diseases, stroke, psychosis and/or depressions.